Summary CardioGenics Inc. (CardioGenics), a subsidiary of CardioGenics Holdings Inc. is a medical device company that manufactures sensitive diagnostic test products to the in-vitro-diagnostics market. The company provides products such as immunoassay tests, QL Care Analyzer, and paramagnetic beads. Its QL Care Analyzer is a portable and automated point of care immune analyzer. CardioGenics provides immunoassay tests such as plasminogen activator inhibitor type-1 test, heart failure genomics risk test, heart failure risk stratification test, and troponin I test. The company also develops a novel, proprietary and patent-protected method to control the delivery of compounds to a chemical reaction, automating the trigger. It also offers beads that are coated with a layer of silver. CardioGenics is headquartered in Mississauga, Ontario, Canada. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company CardioGenics Inc. - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons to Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 4 CardioGenics Inc. Company Snapshot 5 CardioGenics Inc. Company Overview 5 CardioGenics Inc. Pipeline Products and Clinical Trials Overview 6 CardioGenics Inc. - Pipeline Analysis Overview 8 Key Facts 8 CardioGenics Inc. - Major Products and Services 9 CardioGenics Inc. Pipeline Products by Development Stage 10 CardioGenics Inc. Pipeline Products Overview 12 Heart Failure Genomics Risk Test 12 Heart Failure Genomics Risk Test Product Overview 12 Heart Failure Risk Stratification Test 13 Heart Failure Risk Stratification Test Product Overview 13 Plasminogen Activator Inhibitor Type-1 Test 14 Plasminogen Activator Inhibitor Type-1 Test Product Overview 14 QL Care Analyzer 15 QL Care Analyzer Product Overview 15 Troponin-I Test 16 Troponin-I Test Product Overview 16 CardioGenics Inc. - Key Competitors 17 CardioGenics Inc. - Key Employees 18 CardioGenics Inc. - Locations And Subsidiaries 19 Head Office 19 Recent Developments 20 CardioGenics Inc., Recent Developments 20 Aug 25, 2015: CardioGenics Enters Into Manufacturing Agreement With Ontario-Based Plasticap 20 Feb 17, 2015: USPTO Issues Notice of Allowance in Connection With CardioGenics' Self-Metering Cartridge Patent Application 20 Aug 21, 2013: CardioGenics Announces Commencement of Beta-Site Testing 20 Jun 05, 2013: CardioGenics Gets IRB Approval For Beta-Site Testing 21 Apr 03, 2012: CardioGenics Announces Agreements with INO to Manufacture QL Care Analyzers 22 Dec 20, 2011: CardioGenics Announces Submission to IRB for Beta Site Protocol Approval For QL Care Analyzer 22 Dec 20, 2011: CardioGenics Announces Submission to IRB for Beta Site Protocol Approval For Troponin-I cardiovascular test 22 Jun 29, 2011: CardioGenics Receives US Patent For QL Care Analyzer Core Technology 22 Feb 22, 2011: CardioGenics Receives Canadian Patent For QL Care Analyzer Core Technology 23 Feb 03, 2011: CardioGenics To File For 510(k) Clearance With FDA By Fourth Quarter Of 2011 For QL Care Analyzer 23 Appendix 24 Methodology 24 About GlobalData 24 Contact Us 24 Disclaimer 24
List of Tables
CardioGenics Inc. Pipeline Products and Clinical Trials Overview 6 CardioGenics Inc. Pipeline Products by Equipment Type 6 CardioGenics Inc. Pipeline Products by Indication 7 CardioGenics Inc., Key Facts 8 CardioGenics Inc., Major Products and Services 9 CardioGenics Inc. Number of Pipeline Products by Development Stage 10 CardioGenics Inc. Pipeline Products Summary by Development Stage 11 Heart Failure Genomics Risk Test - Product Status 12 Heart Failure Genomics Risk Test - Product Description 12 Heart Failure Risk Stratification Test - Product Status 13 Heart Failure Risk Stratification Test - Product Description 13 Plasminogen Activator Inhibitor Type-1 Test - Product Status 14 Plasminogen Activator Inhibitor Type-1 Test - Product Description 14 QL Care Analyzer - Product Status 15 QL Care Analyzer - Product Description 15 Troponin-I Test - Product Status 16 Troponin-I Test - Product Description 16 CardioGenics Inc., Key Employees 18
List of Figures
CardioGenics Inc. Pipeline Products by Equipment Type 7 CardioGenics Inc. Pipeline Products by Development Stage 10
Global Biocides market size is likely to be valued at USD 11.9 billion by 2022; as per a new research report by Radiant Insights, Inc. Growth in water treatment process units particularly in China, Japan and India is likely to drive demand. IncreasinRead More...
Global glycerol market size is likely to exceed USD 3 billion by 2022, as per a new research report by Radiant Insights, Inc. Regulatory push for promoting bio-diesel production is expected to boost glycerol demand over the forecast period, with expeRead More...
Global integrated systems market is projected to reach USD 24 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing need to re-evaluate data center infrastructure is expected to boost the demand. Change in trend from mainRead More...
Global fingerprint access control systems market size is estimated to reach USD 4.4 billion by 2022, as per a new research report by Radiant Insights, Inc. Growing safety and security concerns of individual as well as organization is projected to driRead More...
Global commercial drone market size is estimated to reach USD 2,069.6 million by 2022, as per a new research report by Radiant Insights, Inc. Increasing application of these machines in various industry sectors such as military, agriculture and energRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.